Educational analysis only — not financial advice. Always do your own due diligence.
LRCX trades against a final fair-value range of $132.71-$237.30, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.
A severe stress test incorporating a 30% reduction to next-year consensus revenue and structurally lower terminal margins drops fair valueFair valueOur composite estimate of intrinsic per-share value, blended across DCF, exit-multiple, and reverse-DCF methods. Reported as a low/mid/high range to capture model uncertainty. toward the $130 level. This highlights the extreme fragility of the current high multiples assigned by the market, which completely ignore inherent downcycle risks.
Extended reduction in NAND and DRAM capex significantly depresses equipment sales and margins beyond modeled downcycle parameters.
Complete ban on trailing-edge and advanced equipment sales to China abruptly eliminates a major high-margin revenue vector.
Competitors dominate next-generation advanced packaging and gate-all-around deposition transitions, permanently eroding Lam's market share.
Cash-flow quality is reflected in the OCFOperating cash flowCash generated from the company's core operations after working-capital changes but before capital expenditures. The first line of the cash-flow statement. / net income, accounting-quality, and ROICROICReturn on invested capital. Operating profit (after tax) divided by invested capital. The single best gauge of capital-efficiency. Spread over WACC = economic value created. rows above.
Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.
